HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,601,877 | +9.7% | 1,033,602 | +4.3% | 0.01% | +10.0% |
| Q2 2023 | $84,409,356 | +8.1% | 991,418 | +5.1% | 0.01% | 0.0% |
| Q1 2023 | $78,093,024 | +108994.4% | 943,722 | +3.7% | 0.01% | 0.0% |
| Q4 2022 | $71,583 | -99.9% | 910,152 | +2.8% | 0.01% | 0.0% |
| Q3 2022 | $65,555,000 | +16.3% | 885,524 | +2.4% | 0.01% | +25.0% |
| Q2 2022 | $56,366,000 | +1.1% | 864,784 | -1.9% | 0.01% | +14.3% |
| Q1 2022 | $55,732,000 | +23.9% | 881,561 | +3.9% | 0.01% | +40.0% |
| Q4 2021 | $44,996,000 | -23.3% | 848,356 | +2.1% | 0.01% | -37.5% |
| Q3 2021 | $58,657,000 | +2.6% | 830,959 | -3.1% | 0.01% | 0.0% |
| Q2 2021 | $57,149,000 | -16.6% | 857,591 | +38.9% | 0.01% | -20.0% |
| Q1 2021 | $68,539,000 | -0.1% | 617,413 | +6.9% | 0.01% | -16.7% |
| Q4 2020 | $68,584,000 | +44.5% | 577,553 | +6.1% | 0.01% | +33.3% |
| Q3 2020 | $47,476,000 | -12.9% | 544,140 | -10.6% | 0.01% | -25.0% |
| Q2 2020 | $54,485,000 | -28.3% | 608,378 | -20.2% | 0.01% | -40.0% |
| Q1 2020 | $75,978,000 | -55.8% | 762,378 | -49.1% | 0.02% | +11.1% |
| Q4 2019 | $171,950,000 | +87.1% | 1,496,540 | +105.4% | 0.02% | -14.3% |
| Q3 2019 | $91,925,000 | +8.7% | 728,761 | +3.7% | 0.02% | +5.0% |
| Q2 2019 | $84,539,000 | +46.0% | 702,502 | +6.1% | 0.02% | +33.3% |
| Q1 2019 | $57,895,000 | -54.0% | 661,822 | -47.4% | 0.02% | -21.1% |
| Q4 2018 | $125,800,000 | +82.6% | 1,257,390 | +109.1% | 0.02% | 0.0% |
| Q3 2018 | $68,902,000 | +25.1% | 601,351 | -2.1% | 0.02% | +11.8% |
| Q2 2018 | $55,059,000 | +49.0% | 613,957 | +21.5% | 0.02% | +41.7% |
| Q1 2018 | $36,963,000 | +33.6% | 505,239 | +6.1% | 0.01% | +33.3% |
| Q4 2017 | $27,657,000 | +28.4% | 476,203 | -0.8% | 0.01% | +12.5% |
| Q3 2017 | $21,547,000 | +19.9% | 480,218 | +5.5% | 0.01% | +14.3% |
| Q2 2017 | $17,971,000 | -0.7% | 455,090 | +2.0% | 0.01% | 0.0% |
| Q1 2017 | $18,096,000 | +12.7% | 446,049 | +11.7% | 0.01% | 0.0% |
| Q4 2016 | $16,051,000 | +25.8% | 399,302 | +13.3% | 0.01% | +16.7% |
| Q3 2016 | $12,763,000 | +30.1% | 352,486 | +4.2% | 0.01% | +20.0% |
| Q2 2016 | $9,809,000 | -17.9% | 338,371 | -0.9% | 0.01% | -16.7% |
| Q1 2016 | $11,946,000 | +17.5% | 341,519 | +8.3% | 0.01% | 0.0% |
| Q4 2015 | $10,165,000 | +0.6% | 315,310 | +0.9% | 0.01% | 0.0% |
| Q3 2015 | $10,101,000 | -21.1% | 312,532 | +1.0% | 0.01% | -14.3% |
| Q2 2015 | $12,797,000 | -3.7% | 309,407 | +4.6% | 0.01% | -12.5% |
| Q1 2015 | $13,286,000 | +25.6% | 295,782 | +4.6% | 0.01% | +33.3% |
| Q4 2014 | $10,579,000 | +8.0% | 282,713 | +0.8% | 0.01% | 0.0% |
| Q3 2014 | $9,797,000 | -0.6% | 280,584 | +0.4% | 0.01% | 0.0% |
| Q2 2014 | $9,860,000 | +9.3% | 279,502 | +0.9% | 0.01% | 0.0% |
| Q1 2014 | $9,025,000 | -15.7% | 276,945 | +9.0% | 0.01% | -14.3% |
| Q4 2013 | $10,703,000 | +17.4% | 254,060 | +11.2% | 0.01% | 0.0% |
| Q3 2013 | $9,113,000 | +4.9% | 228,513 | +8.8% | 0.01% | -12.5% |
| Q2 2013 | $8,688,000 | – | 210,119 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |